189826 InSolution™ 5-Aza-2ʹ-Deoxycytidine - CAS 2353-33-5 - Calbiochem
A cytosine analog that acts as a DNA methyltransferase inhibitor. Restores caspase-8 and caspase-10 mRNA and protein expression as well as TRAIL (Tumor necrosis factor-Related Apoptosis Inducing Ligand) sensitivity in TRAIL-resistant cell lines.
More>> A cytosine analog that acts as a DNA methyltransferase inhibitor. Restores caspase-8 and caspase-10 mRNA and protein expression as well as TRAIL (Tumor necrosis factor-Related Apoptosis Inducing Ligand) sensitivity in TRAIL-resistant cell lines. Less<<FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Synonymes: Decitabine
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| Empirical Formula | CAS # |
|---|---|
| C₈H₁₂N₄O₄ | 2353-33-5 |
Prix & Disponibilité
| Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
|---|---|---|---|---|---|---|
| 189826-10MG |
|
Flacon en verre | 10 mg |
|
— |
| Description | |
|---|---|
| Overview | A cytosine analog that acts as a DNA methyltransferase inhibitor. Restores caspase-8 and caspase-10 mRNA and protein expression as well as TRAIL (Tumor necrosis factor-Related Apoptosis Inducing Ligand) sensitivity in TRAIL-resistant cell lines. Also enhances apoptosis induced by HDAC (Histone Deacetylase) inhibitors. The solid form of this compound (Cat. No. 189825) is also available. |
| Catalogue Number | 189826 |
| Brand Family | Calbiochem® |
| Synonyms | Decitabine |
| Product Information | |
|---|---|
| CAS number | 2353-33-5 |
| Form | Liquid |
| Formulation | A 100 mM (10 mg/438 µl) solution of 5-Aza-2ʹ-Deoxycytidine (Cat. No. 189825) in DMSO. |
| Hill Formula | C₈H₁₂N₄O₄ |
| Chemical formula | C₈H₁₂N₄O₄ |
| Hygroscopic | Hygroscopic |
| Structure formula Image | |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥ 98% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
Documentation
FDS
| Titre |
|---|
Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| 189826 |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
| Eggert, A., et al. 2001. Cancer Res. 61, 1314. Takebayashi, S., et al. 2001. Biochem. Biophys. Res. Commun. 288, 921. Zhu, W.G., et al. 2001. Cancer Res. 61, 1327. Hopkins-Donaldson, S., et al. 2000. Cancer Res. 60, 4315. Haaf, T. 1995. Pharmacol. Ther. 65, 19. Jones, P.A., and Taylor, S.M. 1980. Cell 20, 85. |
Informations techniques
| Titre |
|---|
| White Paper - The Message in the Marks: Deciphering Cancer Epigenetics |
| Fiche technique | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
|